Authors:
Miller, FW
Rider, LG
Chung, YL
Cooper, R
Danko, K
Farewell, V
Lundberg, I
Morrison, C
Oakley, L
Oakley, I
Pilkington, C
Vencovsky, J
Vincent, K
Scott, DL
Isenberg, DA
Citation: Fw. Miller et al., Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies, RHEUMATOLOG, 40(11), 2001, pp. 1262-1273
Authors:
Huber, AM
Hicks, JE
Lachenbruch, PA
Perez, MD
Zemel, LS
Rennebohm, RM
Wallace, CA
Lindsley, CB
Passo, MH
Ballinger, SH
Bowyer, SL
Reed, AM
White, PH
Katona, IM
Miller, FW
Rider, LG
Feldman, BM
Citation: Am. Huber et al., Validation of the childhood health assessment questionnaire iu the juvenile idiopathic myopathies, J RHEUMATOL, 28(5), 2001, pp. 1106-1111
Citation: Jp. Mitchell et al., Juvenile dermatomyositis presenting with anasarca: A possible indicator ofsevere disease activity, J PEDIAT, 138(6), 2001, pp. 942-945
Authors:
Rider, LG
Artlett, CM
Foster, CB
Ahmed, A
Neeman, T
Chanock, SJ
Jimenez, SA
Miller, FW
Citation: Lg. Rider et al., Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies, CLIN EXP IM, 121(1), 2000, pp. 47-52
Authors:
Kimball, AB
Summers, RM
Turner, M
Dugan, EM
Hicks, J
Miller, FW
Rider, LG
Citation: Ab. Kimball et al., Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis - Implications for diagnosis and therapy, ARTH RHEUM, 43(8), 2000, pp. 1866-1873
Authors:
Rider, LG
Shamim, E
Okada, S
Pandey, JP
Targoff, IN
O'Hanlon, TP
Kim, HA
Lim, YS
Han, H
Song, YW
Miller, FW
Citation: Lg. Rider et al., Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites - A tale of two loci, ARTH RHEUM, 42(6), 1999, pp. 1285-1290
Authors:
Lovell, DJ
Lindsley, CB
Rennebohm, RM
Ballinger, SH
Bowyer, SL
Giannini, EH
Hicks, JE
Levinson, JE
Mier, R
Pachman, LM
Passo, MH
Perez, MD
Reed, AM
Schikler, KN
Smith, M
Zemel, LS
Rider, LG
Citation: Dj. Lovell et al., Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies - II. The Childhood Myositis Assessment Scale (CMAS): A quantitative tool for the evaluation of muscle function, ARTH RHEUM, 42(10), 1999, pp. 2213-2219